We serve Chemical Name:1-(4-fluorophenyl)-5-methylpyrazole-4-carbonyl chloride CAS:423768-49-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-fluorophenyl)-5-methylpyrazole-4-carbonyl chloride
CAS.NO:423768-49-4
Synonyms:1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carbonyl chloride
Molecular Formula:C11H8ClFN2O
Molecular Weight:238.64500
HS Code:2933199090
Physical and Chemical Properties:
Melting point:90-92ºC
Boiling point:324.7ºC at 760 mmHg
Density:1.473g/cm3
Index of Refraction:1.57
PSA:34.89000
Exact Mass:238.03100
LogP:2.69880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3265
Packing Group:
Contact us for information like 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carbonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carbonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carbonyl chloride Use and application,1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carbonyl chloride technical grade,usp/ep/jp grade.
Related News: When these modified cells are given back to the patient, they are transported in the bloodstream to the bone marrow where they start to make healthy red blood cells that produce beta-globin. The effects of Zynteglo are expected to last for the patient’s lifetime. ((E)-2-methyl-3-phenyl-2-propenyl)hydrazine sulfate manufacturers When these modified cells are given back to the patient, they are transported in the bloodstream to the bone marrow where they start to make healthy red blood cells that produce beta-globin. The effects of Zynteglo are expected to last for the patient’s lifetime. tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane suppliers A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. 2H-1-Benzopyran-2-one,3,4-dihydro-4-(4-hydroxyphenyl)-5,7-dimethoxy- vendor & factory Altogether, the IPO added $550 million to the family’s collective fortune, which now stands at an estimated $4.8 billion. ,After a four-year battle over a cancer drug patent, Novartis has been ordered by a California judge to pay a Daiichi Sankyo subsidiary $177.8 million.
